ML-IAP is a member of the conserved inhibitor of apoptosis (IAP) family that is highly expressed in melanoma and correlates with aggressive behavior, poor response to chemotherapeutic agents, and decreased survival (Lazar et al., 2012). The gene discussed is BIRC7; the disease is melanoma.